New Rule Amends FDA’s Citizen Petition Regulations to Implement Section 505(q) of the Food, Drug, and Cosmetic Act
D.C. Circuit Issues Landmark Ruling for Stem Cell Therapies
FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity
Subscribe: Subscribe via RSS
Blogs
Firm/Org